Osirium Technologies more than doubled this week after the cybersecurity and IT automation software specialist boasted of a record quarter for bookings.
It must be all those companies worried about attacks from Russian hackers.
The group said it is seeing continued growth in contract values and a return to pre-pandemic levels.
Five of the contracts secured in the first three months of the financial year are each at a larger value than any individual contract signed in fiscal .
Shares in Engage XR, a virtual reality technology company, shot up % this week
Elsewhere in the technology sector, Engage XR, a virtual reality technology company, shot up per cent after an announcement from its partner, VictoryXR.
VictoryXR announced the launch of metaversities in the US this autumn.
Each college or university will roll out a digital twin, replica campus for students to attend whether they are on campus or learning remotely, the statement said.
Just like the real world, students will be able to break into small groups and work on projects together, no matter their physical distance, but unlike the real world, they will be able to shrink to the size of Ant-man and tour the human body, said Steve Grubbs, the chief executive officer of VictoryXR.
Well, I suppose with a name like Grubbs, a weird fixation with insects is understandable …
Another tech success story this week was Journeo, the provider of information systems and technical services to transport operators and local authorities, which announced a new framework agreement with First Bus UK.
The shares motored per cent higher as the company revealed it was the group s largest framework agreement to date. It will initially run for three years until March , is expected to generate £million in revenues and includes an option to extend the term by a further two years through to March .
Shares in Russia-focused oil and gas explorer Petroneft Resources have been out of favour this year for obvious reasons, losing two-thirds of their value in the immediate aftermath of Russia s invasion of Ukraine but the shares attracted buying interest this week, sending them up by more than a third to .p.
It has been a good week for Avacta, the diagnostics company, which issued full-year results on Wednesday.
The oncology firm boasted of a period of transformational progress in , with the group marking its transition into a clinical-stage company with its Therapeutics Division celebrating the dosing of the first patient in the phase I study of the group s AVA asset.
The share price boost from the results was followed on Friday by an even bigger one after AffyXell Therapeutics, Avacta s joint venture with Daewoong Pharmaceutical, entered into a collaboration with Chinese biological drugs developer Biocytogen and the Korea Non-Clinical Technology Solution Centre.
The collaboration is aimed at developing new immune disease in vivo models and carrying out proof-of-concept and toxicity testing of AffyXell s drug candidates using the developed disease models.
Sector peer Omega Diagnostics jumped per cent after it said it saw strong revenue growth last year even as the boost from Covid faded away.
The in-vitro diagnostic products maker said future revenues related to Covid are expected to be minimal but the market focused on the per cent increase in revenues to £.million in the year to the end of March, which was driven by an increase in the contribution from the Health & Nutrition division to £.million from £.million the year before.
Investors are on the lookout for increased production from the oil companies at the best of times but in the current environment, any news of record reserves from an oil producer is sure to attract the attention of the market.
So it proved with i Energy, which said its Canadian subsidiary had record reserves at the end of , while the quarter just ended saw its highest production ever.
The worst performer this week was Sensyne Health, which announced the departure of the company s founder and chief executive alongside financing plans as it said discussions are continuing with a small number of parties interested in buying the business.
Another company on the slide after a funding update and a directorate change was Bonhill, the business-to-business media firm.
Simon Stilwell, its chief executive officer, resigned with immediate effect to pursue other business opportunities. Meanwhile, the company is seeking to raise roughly £.m through the issue of shares at .p.
On Friday, the shares were trading at around .p, down per cent on the week.